Midwest Wealth Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.51M Buy
23,028
+919
+4% +$59.6K 0.92% 63
2021
Q4
$1.54M Buy
22,109
+1,865
+9% +$136K 0.96% 56
2021
Q3
$1.41M Buy
20,244
+578
+3% +$44.5K 0.97% 52
2021
Q2
$1.56M Buy
19,666
+1,029
+6% +$74.8K 1.11% 40
2021
Q1
$1.22M Buy
18,637
+841
+5% +$51.8K 0.99% 46
2020
Q4
$991K Buy
+17,796
New +$769K 0.91% 49

Other funds holding ATRC

Midwest Wealth Management's ATRC Position: Q1 2022 in Review

Midwest Wealth Management increased its AtriCure (ATRC) stake by 4.2% in Q1 2022, buying an estimated $59.6K and bringing the position to 23,028 shares worth $1.51M. The position accounts for 0.92% of the portfolio, ranked #63.

Midwest Wealth Management first reported a position in ATRC in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.56M in Q2 2021. 217 funds tracked by Wall St. Rank hold ATRC as of Q1 2022.

  • Midwest Wealth Management held 23,028 shares of AtriCure worth $1.51M as of Q1 2022.
  • Midwest Wealth Management bought 919 AtriCure shares in Q1 2022, an estimated $59.6K.
  • AtriCure made up 0.92% of Midwest Wealth Management's portfolio in Q1 2022, its #63 holding.
  • Midwest Wealth Management first reported a position in AtriCure in Q4 2020 and has held it in 6 quarters since.
  • Midwest Wealth Management's AtriCure position peaked at $1.56M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q1 2022.

Based on Midwest Wealth Management's 13F filing for Q1 2022, filed 25 May 2022.